Former Boston Scientific’s Fluid Management and Vascular Access businesses have adopted a new company name, Navilyst Medical, following the February acquisition by Avista Capital Partners, a U.S. private equity firm.
Navilyst of Marlborough, Mass., said it manufactures and markets fluid management and vascular access products used during procedures, such as angiography and angioplasty. Navilyst’s fluid management business includes the proprietary Namic line of products, and its vascular access products include devices designed to provide access to the blood stream for patients requiring intravenous antibiotics, blood sampling and hemodialysis.
The company said its Pasv technology is designed to automatically close after infusion, disconnection or aspiration, and remain closed during normal pressure fluctuations, according to the company.
Navilyst employs approximately 800 people, with an ISO-certified manufacturing plant in Glens Falls, NY. The company plans to launch several new products during the upcoming year.
“This strong combination of product heritage and experienced employees able to execute on this vision captured Avista’s interest in the deal from the outset. By 2011, the company should look very different than we do today," added Navilyst CEO Ron Sparks.